146 related articles for article (PubMed ID: 25847223)
1. IL-6 blockade reverses the abnormal STAT activation of peripheral blood leukocytes from rheumatoid arthritis patients.
Ortiz MA; Diaz-Torné C; Hernández MV; Reina D; de la Fuente D; Castellví I; Moya P; Ruiz JM; Corominas H; Zamora C; Cantó E; Sanmartí R; Juarez C; Vidal S
Clin Immunol; 2015 Jun; 158(2):174-82. PubMed ID: 25847223
[TBL] [Abstract][Full Text] [Related]
2. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
[TBL] [Abstract][Full Text] [Related]
3. IL-6-driven STAT signalling in circulating CD4+ lymphocytes is a marker for early anticitrullinated peptide antibody-negative rheumatoid arthritis.
Anderson AE; Pratt AG; Sedhom MA; Doran JP; Routledge C; Hargreaves B; Brown PM; Lê Cao KA; Isaacs JD; Thomas R
Ann Rheum Dis; 2016 Feb; 75(2):466-73. PubMed ID: 25649145
[TBL] [Abstract][Full Text] [Related]
4. Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis.
Karonitsch T; von Dalwigk K; Steiner CW; Blüml S; Steiner G; Kiener HP; Smolen JS; Aringer M
Arthritis Rheum; 2012 Feb; 64(2):400-8. PubMed ID: 21953607
[TBL] [Abstract][Full Text] [Related]
5. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
[TBL] [Abstract][Full Text] [Related]
6. Local and systemic alterations in signal transducers and activators of transcription (STAT) associated with human abdominal aortic aneurysms.
Liao M; Xu J; Clair AJ; Ehrman B; Graham LM; Eagleton MJ
J Surg Res; 2012 Jul; 176(1):321-8. PubMed ID: 21764069
[TBL] [Abstract][Full Text] [Related]
7. A new bioassay for measuring the strength of IL-6/STAT3 signal inhibition by tocilizumab in patients with rheumatoid arthritis.
Saito S; Suzuki K; Yoshimoto K; Kaneko Y; Matsumoto Y; Yamaoka K; Takeuchi T
Arthritis Res Ther; 2017 Oct; 19(1):231. PubMed ID: 29041951
[TBL] [Abstract][Full Text] [Related]
8. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.
Ju JH; Heo YJ; Cho ML; Jhun JY; Park JS; Lee SY; Oh HJ; Moon SJ; Kwok SK; Park KS; Park SH; Kim HY
Arthritis Rheum; 2012 Nov; 64(11):3543-52. PubMed ID: 22736176
[TBL] [Abstract][Full Text] [Related]
9. STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis.
Kuuliala K; Kuuliala A; Koivuniemi R; Kautiainen H; Repo H; Leirisalo-Repo M
PLoS One; 2016; 11(12):e0167975. PubMed ID: 27942004
[TBL] [Abstract][Full Text] [Related]
10. Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility.
Aue A; Szelinski F; Weißenberg SY; Wiedemann A; Rose T; Lino AC; Dörner T
Rheumatology (Oxford); 2020 Nov; 59(11):3435-3442. PubMed ID: 32357246
[TBL] [Abstract][Full Text] [Related]
11. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
[TBL] [Abstract][Full Text] [Related]
12. Impaired IL-6-induced JAK-STAT signaling in CD4
Esen I; Sandovici M; Heeringa P; Boots AMH; Brouwer E; van Sleen Y; Abdulahad W
J Autoimmun; 2024 Jun; 146():103215. PubMed ID: 38653164
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
Kikuchi J; Hashizume M; Kaneko Y; Yoshimoto K; Nishina N; Takeuchi T
Arthritis Res Ther; 2015 Jan; 17(1):10. PubMed ID: 25604867
[TBL] [Abstract][Full Text] [Related]
15. pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy.
Madia F; Frisullo G; Nociti V; Conte A; Luigetti M; Del Grande A; Patanella AK; Iorio R; Tonali PA; Batocchi AP; Sabatelli M
J Peripher Nerv Syst; 2009 Jun; 14(2):107-17. PubMed ID: 19691533
[TBL] [Abstract][Full Text] [Related]
16. Constitutive STAT3 Phosphorylation in Circulating CD4+ T Lymphocytes Associates with Disease Activity and Treatment Response in Recent-Onset Rheumatoid Arthritis.
Kuuliala K; Kuuliala A; Koivuniemi R; Oksanen S; Hämäläinen M; Moilanen E; Kautiainen H; Leirisalo-Repo M; Repo H
PLoS One; 2015; 10(9):e0137385. PubMed ID: 26353115
[TBL] [Abstract][Full Text] [Related]
17. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
[TBL] [Abstract][Full Text] [Related]
18. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
[TBL] [Abstract][Full Text] [Related]
19. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
[TBL] [Abstract][Full Text] [Related]
20. Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activity.
Ptacek J; Hawtin RE; Sun D; Louie B; Evensen E; Mittleman BB; Cesano A; Cavet G; Bingham CO; Cofield SS; Curtis JR; Danila MI; Raman C; Furie RA; Genovese MC; Robinson WH; Levesque MC; Moreland LW; Nigrovic PA; Shadick NA; O'Dell JR; Thiele GM; Clair EWS; Striebich CC; Hale MB; Khalili H; Batliwalla F; Aranow C; Mackay M; Diamond B; Nolan GP; Gregersen PK; Bridges SL
PLoS One; 2021; 16(1):e0244187. PubMed ID: 33444321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
